MRA Request for Proposals

Funding Agency:
Melanoma Research Alliance

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment.

The 2021 - 2022 award cycle, is anticipated to support at least $11.3 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. 

Special Opportunities Included in RFP:

  • MRA Young Investigator, Pilot, and Team Science Awards for Women in Melanoma Research
  • Immunotherapy Young Investigator Awards supported by Bristol Myers Squibb (BMS).

Please note the following key deadlines:

  • October 6: Team Science Award Letters of Intent Due
  • November 3: Young Investigator Award Eligibility Checklist Due to rfischer@curemelanoma.org.
  • November 17: Young Investigator and Pilot Awards Full Proposals Due
  • January 19: Team Science Award Full Proposals Due (from invited applicants)

Agency Website

Eligibility Requirements

 

MRA accepts proposals from researchers worldwide and encourages applications from a diverse pool of investigators with respect to race, gender, sexual orientation, ethnicity, national origin, country of residence, and disability. MRA recognizes that diversity in the biomedical research workforce is critical for ensuring that the most creative minds have the opportunity to contribute to realizing our research goals and to ensuring more equitable health outcomes for all.

Funding Type

Grant

Eligibility

Faculty
Junior Faculty
Women and minorities encouraged

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 6, 2021